Trends in Genetics

Trends in Genetics
Title	Trends in Genetics
Discipline	Genetics, Genomics, Molecular Biology
Abbreviation	Trends Genet.
Publisher	Elsevier
Country	United Kingdom
History	1985–present
Frequency	Monthly
Issn	0168-9525

Trends in Genetics is a peer-reviewed review journal that synthesizes developments in Genetics and Molecular Biology with emphasis on conceptual advances and thematic reviews. Launched in 1985 by Elsevier as part of the Trends series, it has published reviews by leading investigators from institutions such as Harvard University, Massachusetts Institute of Technology, Stanford University, University of Cambridge, and University of Oxford. The journal interfaces with professional societies and policy bodies including the Genetics Society of America, European Molecular Biology Organization, and National Institutes of Health through commissioned articles and perspectives.

Overview

Trends in Genetics produces review articles, opinion pieces, and special issues that address topics spanning Human Genome Project, CRISPR-Cas9, Epigenetics, Population genetics, and Evolutionary biology. The editorial model emphasizes synthesis over primary data, engaging authors from centers like Broad Institute, Wellcome Sanger Institute, Cold Spring Harbor Laboratory, Max Planck Institute for Evolutionary Anthropology, and Karolinska Institutet. Articles often cross-reference major projects such as the 1000 Genomes Project, ENCODE Project, Human Cell Atlas, and Cancer Genome Atlas to contextualize advances for researchers affiliated with National Human Genome Research Institute, European Commission, and research funders like the Wellcome Trust.

History and Development

Founded amid the expansion of molecular genetics in the 1980s, Trends in Genetics emerged contemporaneously with landmark events including the initiation of the Human Genome Project and the establishment of the Royal Society’s policy dialogues on recombinant DNA. Early editors commissioned reviews on recombinant DNA technology, linkage mapping, and model organisms such as Drosophila melanogaster, Caenorhabditis elegans, and Arabidopsis thaliana. Through the 1990s and 2000s, the journal tracked paradigm shifts driven by contributions from groups at University of California, Berkeley, Johns Hopkins University, European Molecular Biology Laboratory, and corporate research labs like Illumina, reflecting transitions from Sanger sequencing to next-generation sequencing and from single-gene studies to systems-level approaches.

Major Research Themes

Recurring themes include genome editing exemplified by research from teams associated with Jennifer Doudna, Emmanuelle Charpentier, and laboratories at University of California, San Francisco; epigenomic regulation described by investigators at The Salk Institute and University College London; and comparative genomics work from groups at University of Chicago and University of California, Santa Cruz. Reviews synthesize population-level studies linked to cohorts like the UK Biobank and collaborations involving European Molecular Biology Organization members. Functional genomics, transcriptomics, single-cell biology from centers such as Stanford University School of Medicine and MIT Broad Institute also appear frequently, as do analyses of ethical, legal, and social implications raised in panels including National Academies of Sciences, Engineering, and Medicine and the World Health Organization.

Publication and Editorial Practices

The journal follows editorial practices coordinated by editors and an international editorial board with members from Princeton University, Yale University, University of California, San Diego, and ETH Zurich. Commissioned reviews are common, with solicitation from experts including Nobel laureates and leaders of consortia like the International HapMap Consortium. Peer review focuses on conceptual clarity and synthesis rather than primary-data reproducibility, aligning with practices at other review journals such as Nature Reviews Genetics and Annual Review of Genomics and Human Genetics. Special issues often coincide with meetings hosted by organizations like the Cold Spring Harbor Laboratory and the Gordon Research Conferences.

Impact on Genetics Research and Policy

Trends in Genetics articles have influenced citation networks and pedagogical curricula at universities such as Columbia University, University of Toronto, and McGill University. Policy discussions that cite its reviews have appeared in briefings by United Nations Educational, Scientific and Cultural Organization, European Parliament, and national advisory panels including those convened by the U.S. Food and Drug Administration. The journal’s syntheses have guided funding priorities at agencies like the European Research Council and the U.S. National Science Foundation by clarifying emergent directions such as precision medicine initiatives championed by institutions like Mayo Clinic and Genentech.

Criticisms and Controversies

Critiques have focused on reliance on commissioned content and potential editorial selection bias favoring established institutions including Harvard Medical School and Rockefeller University. Discussions in academic forums and commentary pieces have paralleled controversies in other outlets such as Science and Nature about the balance between expert synthesis and inclusivity of early-career voices from places like Indian Institutes of Technology and Peking University. Debates also reflect broader disputes over open access policies advocated by groups like Plan S and publishers including Elsevier, and concerns about conflicts of interest when articles intersect with biotechnology companies such as Thermo Fisher Scientific and Roche.

Future Directions and Emerging Topics

Anticipated directions include expanded coverage of technologies and consortia such as single-cell multiomics involving teams at Scripps Research, spatial transcriptomics led by labs at University of Copenhagen, and integrative computational efforts from groups at Google DeepMind and OpenAI collaborating with academic centers. Emerging topics likely to be featured include synthetic genomics from initiatives at Ginkgo Bioworks, gene drives debated at forums like Convention on Biological Diversity, and regulatory genomics informing policy bodies such as the European Medicines Agency. Continued interaction with global research infrastructures—Global Alliance for Genomics and Health, ELIXIR, and national biobanks—will shape the journal’s role in synthesizing genetics knowledge for science and policy communities.

Category:Genetics journals